Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

High-throughput screening of hybridoma supernatants using multiplexed fluorescent cell barcoding on live cells.

Lu M, Chan BM, Schow PW, Chang WS, King CT.

J Immunol Methods. 2017 Dec;451:20-27. doi: 10.1016/j.jim.2017.08.002. Epub 2017 Aug 11.

PMID:
28803843
2.

Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR.

Am J Pathol. 2012 Nov;181(5):1573-84. doi: 10.1016/j.ajpath.2012.07.030. Epub 2012 Sep 27.

3.

Knocking out multigene redundancies via cycles of sexual assortment and fluorescence selection.

Suzuki Y, St Onge RP, Mani R, King OD, Heilbut A, Labunskyy VM, Chen W, Pham L, Zhang LV, Tong AH, Nislow C, Giaever G, Gladyshev VN, Vidal M, Schow P, Lehár J, Roth FP.

Nat Methods. 2011 Feb;8(2):159-64. doi: 10.1038/nmeth.1550. Epub 2011 Jan 9.

4.

APRIL-deficient mice have normal immune system development.

Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A.

Mol Cell Biol. 2004 Feb;24(3):997-1006.

5.

Development of a frozen cell array as a high-throughput approach for cell-based analysis.

Stephan JP, Schanz S, Wong A, Schow P, Wong WL.

Am J Pathol. 2002 Sep;161(3):787-97.

6.

Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.

Ross S, Spencer SD, Holcomb I, Tan C, Hongo J, Devaux B, Rangell L, Keller GA, Schow P, Steeves RM, Lutz RJ, Frantz G, Hillan K, Peale F, Tobin P, Eberhard D, Rubin MA, Lasky LA, Koeppen H.

Cancer Res. 2002 May 1;62(9):2546-53.

7.

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A.

Nat Med. 2002 Mar;8(3):274-81.

PMID:
11875499
8.

Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3.

Liang TW, Chiu HH, Gurney A, Sidle A, Tumas DB, Schow P, Foster J, Klassen T, Dennis K, DeMarco RA, Pham T, Frantz G, Fong S.

J Immunol. 2002 Feb 15;168(4):1618-26.

9.

Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice.

Pan G, French D, Mao W, Maruoka M, Risser P, Lee J, Foster J, Aggarwal S, Nicholes K, Guillet S, Schow P, Gurney AL.

J Immunol. 2001 Dec 1;167(11):6559-67.

10.

Mental stimulation increases circulating CD4-positive T lymphocytes: a preliminary study.

Diamond MC, Weidner J, Schow P, Grell S, Everett M.

Brain Res Cogn Brain Res. 2001 Oct;12(2):329-31.

PMID:
11587902
11.

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.

Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A.

J Biol Chem. 2001 Dec 7;276(49):46639-46. Epub 2001 Oct 2.

12.

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.

Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D, Ashkenazi A.

Nat Med. 2001 Apr;7(4):383-5. No abstract available.

PMID:
11283636
13.
14.

Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation.

Yu XX, Mao W, Zhong A, Schow P, Brush J, Sherwood SW, Adams SH, Pan G.

FASEB J. 2000 Aug;14(11):1611-8.

PMID:
10928996
15.

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A.

Immunity. 2000 Jun;12(6):611-20.

16.

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, Cameron C, Schow P, Ross ME, Klumpp TR, Soiffer RJ, et al.

J Clin Invest. 1993 Jan;91(1):123-32.

17.

Follicular dendritic cells inhibit human B-lymphocyte proliferation.

Freedman AS, Munro JM, Rhynhart K, Schow P, Daley J, Lee N, Svahn J, Eliseo L, Nadler LM.

Blood. 1992 Sep 1;80(5):1284-8.

PMID:
1515644
18.

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.

Soiffer RJ, Murray C, Cochran K, Cameron C, Wang E, Schow PW, Daley JF, Ritz J.

Blood. 1992 Jan 15;79(2):517-26.

PMID:
1730094
19.

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.

Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.

Eur J Immunol. 1992 Jan;22(1):1-6.

PMID:
1370410
20.

Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.

Dang NH, Torimoto Y, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C.

J Immunol. 1990 Dec 15;145(12):3963-71.

PMID:
1979581
21.

Fatal liver disease associated with alpha 1-antitrypsin deficiency PiM1/PiMduarte.

Crowley JJ, Sharp HL, Freier E, Ishak KG, Schow P.

Gastroenterology. 1987 Aug;93(2):242-4.

PMID:
3297908
22.

Splenic artery aneurysm-pancreatic duct fistula.

Lung JA, Schow PD, Knight L.

Am J Surg. 1980 Mar;139(3):430-1.

PMID:
6965825
23.

Letter: Methemalbumin and pancreatitis: a warning.

Schow PD, Englert E.

Ann Intern Med. 1975 Feb;82(2):281-2. No abstract available.

PMID:
1115454

Supplemental Content

Support Center